top of page
VA.jpg

IN THE STATES

VIRGINIA

The economic footprint of the biopharmaceutical industry can be measured by traditional indicators of employment and output, and its impact on the vendors, large and small, that provide services or supplies to America's biopharmaceutical research companies. The data below illustrates jobs, economic impact and clinical trial data for the industry as a whole, and vendor/supplier data from 15 major biopharmaceutical companies regarding their business relationships and total expenditures paid to vendors in Virginia in 2022.

VA.png

Economic
Output

$16.4B

Direct Jobs Supported by the Industry

11,481

Total Jobs Supported

55,541

State Total Vendor Relationships

1,242

State Total Vendor Spending

$723,109,964

Clinical
Trials

759

Investments at Clinical Trial Sites

$267.2M

Clinical Trial Participants

17,685

Total Economic Impact of Clinical Trial Sites

$695.7M

bottom of page